This bill increases the age limit for children to remain eligible for medical care under the CHAMPVA program from 21 to 26 years old, regardless of marital status. It directly affects the children of veterans who qualify for CHAMPVA benefits. The key provision amends Section 1781(c) of Title 38, U.S. Code, to extend coverage until a child's 26th birthday. This change applies to medical care provided on or after the bill's enactment date. It does not affect children already covered under specific existing provisions of the law.
The DRIVE Act of 2025 updates how the Department of Veterans Affairs reimburses veterans for using personal vehicles for VA-related travel. It requires the VA to set mileage reimbursement rates equal to or higher than the federal government’s standard rate for employee travel (currently 41.5 cents per mile), replacing the fixed rate in current law. The bill also mandates that veterans receive these reimbursements within 90 days of submitting a valid claim. This directly affects veterans who travel for VA appointments or services using their personal vehicles.
This bill prohibits the U.S. military from discriminating against service members or applicants based on gender identity. It bans policies that would deny service, involuntarily separate members, deny medically necessary healthcare, or require service in a gender different from one's identity. The law defines "gender identity" broadly to include a person's internal sense of gender, appearance, and mannerisms, regardless of sex assigned at birth. It directly affects transgender and gender-diverse individuals currently serving or seeking to serve in the Armed Forces.
This bill prohibits the President from selling, transferring, or exporting certain defense articles or services to Israel, except in specified circumstances. Defense articles covered by the prohibition include BLU-109 bunker busting bombs, Joint Direct Attack Munition (JDAM) assemblies, and 155mm artillery ammunition. Defense services directly related to such articles are also covered. The President may sell, transfer, or export such defense articles or services to Israel if (1) a law is enacted specifying the purposes for which such articles or services may be used, and (2) Israel provides written assurances that the defense articles or services will be used for those specific statutory purposes and in a manner consistent with certain other laws, including international human rights laws.
The College for All Act of 2025 would eliminate tuition and required fees for eligible students at public community colleges and 4-year institutions through a federal-state partnership. The federal government would cover 100% of costs in the first year (2026-2027), gradually decreasing to 80% by 2030-2031, while states would start with 0% and increase to 20% by 2030-2031. Eligible students would include those with family income below $150,000 for single parents or $300,000 for married parents, regardless of immigration status. The bill also includes requirements to maintain instruction funding, improve transfer pathways between community colleges and 4-year institutions, and provide additional support for students after tuition elimination.
This bill would establish 18-year fixed terms for all Supreme Court justices, replacing lifetime appointments. It requires the President to nominate one justice every two years (during first and third years after presidential elections), with Senate confirmation within 90 days, and prohibits reappointments after a single term. Current justices would be phased out in order of seniority as new justices are appointed under this schedule. The bill directly affects all sitting and future Supreme Court justices by mandating term limits and a structured appointment process.
HR 3534, the Mental Health in Schools Excellence Program Act of 2025, creates a federal program to increase the number of school-based mental health professionals. It provides federal matching funds - covering up to 50% of tuition and fees for eligible students - in partnership with graduate schools offering accredited programs in school counseling, psychology, or social work. Participating graduate institutions must match federal contributions, and priority is given to students who received Federal Pell Grants or attended specific institutions as undergraduates. The program directly affects graduate students training to become licensed school mental health providers, aiming to expand the workforce serving K-12 schools.
SRES 236 is a non-binding Senate resolution condemning Russia’s abduction and forced transfer of Ukrainian children, citing over 19,500 confirmed cases as of April 2025. It urges that all Ukrainian children abducted by Russia be returned before any peace agreement is finalized, emphasizing this as a prerequisite for a just resolution to the war. The resolution references Russia’s changed adoption laws, violations of international treaties, and documented human rights abuses against children in occupied territories. It does not create new law but formally expresses the Senate’s position on this issue.
The Supreme Court Ethics, Recusal, and Transparency Act of 2025 would establish a formal code of conduct for Supreme Court justices and require them to disclose gifts and financial interests. It creates procedures for filing complaints about justices' conduct, including a judicial investigation panel to review allegations of misconduct. The bill expands circumstances requiring justices to recuse themselves from cases, such as when they or their family received gifts from parties involved in a case. These provisions aim to increase transparency and accountability in the Supreme Court's operations, with new disclosure requirements for parties and amici curiae in court cases.
This bill creates a process for the Secretary of Health and Human Services to determine if brand name drug prices exceed those in five reference countries (Canada, UK, Germany, France, and Japan). If a drug is deemed excessively priced, the government will terminate the manufacturer's exclusivity rights and allow any company to produce a generic version under an open, non-exclusive license with a reasonable royalty. Drug manufacturers must submit detailed annual reports on pricing, costs, and revenues, with penalties for noncompliance. The Secretary will maintain a public database of excessive price determinations and report annually to Congress. This directly impacts brand name drug manufacturers, generic producers, and patients who purchase prescription drugs.
This bill increases fines for unauthorized access to or disclosure of sensitive government data. It raises the maximum civil penalty for violating the Privacy Act from $5,000 to $30,000 per violation (Section 2), and increases criminal fines for unauthorized computer access to up to $750,000 for individuals (Section 3). Specific provisions also raise fines for improper disclosure of Social Security data ($10,000 → $25,000), tax information ($5,000 → $25,000), and census data ($5,000 → $25,000) (Sections 4-6). The bill directly affects government employees, contractors, and others handling protected data by making violations more costly. It focuses solely on penalty adjustments without creating new data collection or oversight requirements. (Note: "DOGE BROS" is a non-official, informal reference in the bill's title.)
This bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2028 and report detailed transparency data starting in 2027. Plans must publicly disclose approval/denial rates, average processing times (including for appeals), technology use, and other metrics for covered medical services. It mandates 24-hour response standards for expedited requests and routinely approved services, with data collection to analyze access patterns and potential disparities in rural/low-income communities. These changes directly affect Medicare Advantage plans, providers, and seniors enrolled in these plans by standardizing and increasing visibility into prior authorization processes.
